Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-079104
Filing Date
2025-05-29
Accepted
2025-05-29 17:02:32
Documents
1
Period of Report
2025-05-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3711
  Complete submission text file 0000950170-25-079104.txt   5377
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Issuer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065
Business Address
Nabel Gary J. (Reporting) CIK: 0001867450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33528 | Film No.: 251004493